Europe's fundraise calendar delivered breadth over concentration this week. No single nine-figure headline dominated. Instead, capital spread across tokenised finance, biotech, quantum computing, clean energy, healthcare AI, and legal infrastructure. The week's biggest EU-headquartered round was Spiko's $90 million Series B for tokenised cash funds, but the real story is the variety: a Dutch biotech launching with $58 million, a German fuel cell company closing $175 million, and a British quantum computing startup pulling in over $100 million in what it calls the UK's largest quantum Series A.

Headline Raise: Spiko, $90M Series B

Company: Spiko
Amount: $90 million, Series B
Lead investor: New Enterprise Associates (NEA)
Other investors: Index Ventures, Bpifrance, Speedinvest, Flourish Ventures, White Star Capital, Blockwall, Frst, EQNX, Mirana, Shapers
HQ: London and Paris
Total raised to date: $120 million

Spiko builds tokenised cash funds, infrastructure that lets businesses and institutions earn yield on cash reserves through blockchain-native money market products. The company sits at the intersection of traditional finance and crypto rails, regulated in both the UK and France.

Announcement Strategy Teardown

Spiko's announcement ran simultaneously through Yahoo Finance (wire distribution), Startup.eu, CypherHunter, and Seedtable. The company timed the announcement for Monday 6th October, a quiet news day that avoided competing with the Sifted Summit (7th-8th October in London, where most European tech journalists were occupied).

The investor list carried the narrative. NEA leading a European fintech round is notable because it signals US institutional conviction. Index Ventures and Bpifrance add European credibility. Flourish Ventures (fintech-specialist) and Blockwall (crypto-native) together signal that both traditional fintech and crypto investors see this product as real infrastructure, not speculation.

Spiko did not lead with crypto. The framing was "tokenised cash funds" and "yield," language that resonates with CFOs, not just DeFi traders. That is a deliberate positioning choice for a company that needs regulated institutional adoption.

Actionable Insights

1. Time your announcement against the conference calendar. Sifted Summit ran 7th-8th October. Spiko announced on the 6th, grabbing the pre-conference news window. If you are raising while a major industry event is pulling journalist attention, announce the day before the event opens, not during it.

2. Frame the category for your buyer, not your builder. "Tokenised cash funds" sounds like treasury management. "DeFi yield protocol" sounds like crypto Twitter. Spiko chose the framing that matches its target customer. If your technology has a consumer-grade explanation and a builder-grade explanation, lead with the one your buyer recognises.

3. Dual-jurisdiction regulation is a fundraise asset. Spiko is regulated in both the UK and France. That is expensive and slow, but it meant the announcement could reference both markets credibly. For European fintechs, regulatory licences in multiple jurisdictions are becoming a competitive moat worth highlighting in fundraise comms.

Other Notable EU Rounds This Week

  • Reverion (Eresing, Germany) raised $175M Series B (Kembara, Allianz, KfW Capital, Aurum Impact, Carbon Equity) to scale production of its reversible fuel cell power plants. Dispatchable, carbon-negative power for data centres and grids. Announced 29th September but circulated heavily this week.
  • Universal Quantum (Haywards Heath, UK) raised over $100M Series A (DCVC, Firgun Ventures, EDBI Singapore, Roblox CEO David Baszucki). The largest Series A for a UK quantum computing company. Modular trapped-ion architecture built on conventional semiconductor fabrication.
  • RougeTx (Naarden, Netherlands) launched with a $58M Series A to advance a first-in-class oral treatment for hereditary hemorrhagic telangiectasia (HHT), targeting pericyte dysfunction. A Leiden University Medical Center spin-out.
  • Sensible Biotechnologies raised $47M for biotech research.
  • Hadrian raised $40M in a growth round.
  • WhiteLab Genomics raised $26M.
  • Vocca (New York and Paris) raised $20M Series A (Norrsken VC, Heal Capital, Speedinvest, Firstminute Capital) for AI phone assistants serving medical practices. Grew from 2,000 to 15,000 practitioners in one year. Datadog and Alan founders invested as angels.
  • Procuros raised EUR20M; finmid raised EUR17M; Pandektes raised EUR13.5M Series A (Alstin Capital) for legal data infrastructure.